25
2025
Roche
CFO
Thomas
Schinecker
Head IR
Bruno
Eschli
ZKB Analyst: Marcel Brand
One-on-one, Small group meeting
Roche is focussing solely on specialty pharma, mainly against cancer, and modern molecular diagnostics.